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Purpose: The aim of this paper is to investigate whether bioelectrical impedance vector analysis 
(BIVA) can be a suitable technique for the assessment of sarcopenia. We also investigate the 
potential use of specific BIVA as an indicator of sarcopenic obesity.
Subjects and methods: The sample comprised 207 free-living elderly individuals of both 
sexes, aged 65 to 93 years. Anthropometric and bioelectrical measurements were taken accord-
ing to standard criteria. The “classic” and “specific” BIVA procedures, which respectively 
correct bioelectrical values for body height and body geometry, were used. Dual energy X-ray 
absorptiometry (DXA) was used as the reference method for identifying sarcopenic and obese 
sarcopenic individuals. Bioelectrical and DXA values were compared using Student’s t-test and 
Hotelling’s T 2 test, as well as Pearson’s correlation coefficient.
Results: According to classic BIVA, sarcopenic individuals of both sexes showed higher values 
of resistance/height (R/H; p , 0.01) and impedance/height (Z/H; p , 0.01), and a lower phase 
angle (p , 0.01). Similarly, specific BIVA showed significant differences between sarcopenic 
and nonsarcopenic individuals (men: T2 = 15.7, p , 0.01; women: T 2 = 10.7, p , 0.01), with 
the sarcopenic groups showing a lower specific reactance and phase angle. Phase angle was 
positively correlated with the skeletal muscle mass index (men: r = 0.52, p , 0.01; women: 
r = 0.31, p , 0.01). Specific BIVA also recognized bioelectrical differences between sarcopenic 
and sarcopenic obese men (T2 = 13.4, p , 0.01), mainly due to the higher values of specific R 
in sarcopenic obese individuals.
Conclusion: BIVA detected muscle-mass variations in sarcopenic individuals, and specific 
BIVA was able to discriminate sarcopenic individuals from sarcopenic obese individuals. These 
procedures are promising tools for screening for presarcopenia, sarcopenia, and sarcopenic 
obesity in routine practice.
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Introduction
Physiological aging is associated with large and progressive body composition varia-
tions, particularly a decline of fat-free mass (FFM),1 that expose elderly individuals 
to the risk of geriatric syndromes such as sarcopenia2 and sarcopenic obesity.3
According to the current consensus on definitions of the syndrome,4–8  sarcopenia 
is characterized by both muscle-mass reduction and low muscle strength or  physical 
 performance.8 The European Working Group on Sarcopenia in Older People 
(EWGSOP) also defined a “presarcopenia” stage characterized by low muscle mass 
in reference to the standard population, without muscle strength or functional impair-
ment, and a “severe sarcopenia” stage that appears when the three deficits – muscle 
mass, strength, and function loss – are present.4
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Sarcopenic obesity arises when a low muscle mass is associ-
ated with obesity.3 Stenholm et al9 suggested the term “obesity/
muscle impairment syndrome,” which is related to the loss 
of muscle function rather than the loss of muscle mass only. 
The impact of adipose tissue on sarcopenia is also relevant 
because of the fat infiltration into muscle observed in older 
individuals,10 which can be associated with lower muscle per-
formance.11,12 To account for these variations, the simultaneous 
evaluation of fat and muscle have been recommended.8
The suggested techniques for the assessment of body 
composition in research and practice are body-imaging tech-
niques, computed tomography (CT), and magnetic resonance 
imaging (MRI) as the gold standards, and dual energy X-ray 
absorptiometry (DXA) as the preferred alternative method.4,8 
The EWGSOP indicated bioelectrical impedance analysis 
(BIA) is “a good portable alternative” method.4 With its low 
cost and because it is quick and simple to use, BIA has also 
been suggested for the “systematic and repeated evaluation of 
FFM in clinical practice.”13 However, the traditional approach 
using prediction equations has been questioned because of 
the variable level of body hydration between individuals, and 
the technique has been discouraged for the assessment of 
sarcopenia.6,8
Bioelectrical impedance vector analysis (BIVA) is an inter-
esting alternative approach to BIA that allows the evaluation of 
body cell mass and hydration without the need for predictive 
equations.14 It has been used to evaluate many pathological 
conditions15 and is demonstratively sensitive to hand-grip 
strength variations.16 However, classic BIVA showed low 
efficacy when evaluating body-fat percentage.17 A recently 
proposed variant of classic BIVA, “specific” BIVA, has been 
shown to accurately identify body-fat variations in a sample of 
elderly Italian aged 65 to 93 years17 and in a sample of adults 
from the US (Buffa et al, unpublished data, 2012).
The aim of this paper is to show that BIVA can be a suitable 
technique for the assessment of sarcopenia in clinical routine 
practice by comparing the results with those obtained using 
DXA. Moreover, we aim to show the potential use of specific 
BIVA to evaluate fat mass, looking ahead to the use of this 
new procedure for the assessment of sarcopenic obesity.
Subjects and methods
Subjects
The study group consisted of 207 individuals (132 women 
and 75 men) aged 65 years and over (mean age 70.8 ± 4.0 in 
women and 75.8 ± 6.9 in men). All individuals were born and 
resided in Italy. The volunteers were recruited from public 
gyms in Padua, Italy. Medical personnel from the Geriatrics 
Department of Padua University established volunteers’ 
health conditions using clinical history, clinical examination, 
and biochemical test results. The following were the exclu-
sion criteria: severe cardiovascular or pulmonary disease, 
uncontrolled metabolic disease (diabetes, anemia, or thyroid 
disease), electrolyte abnormalities, cancer, or inflammatory 
conditions. Moreover, individuals with bioelectrical charac-
teristics indicative of dehydration (four women and one man) 
on the basis of BIVA were omitted from the analyses.
In accordance with the Helsinki Declaration of 1975, 
as revised in 2008, all subjects were informed about the 
objectives and methods of the research, and the individuals 
consented to participate in the study.
Measurements
Detailed personal information, behavioral information, and 
medical history were collected by means of a structured 
interview. Anthropometrical (five variables), bioelectrical 
(two variables), and DXA (15 variables) measurements 
were taken in the morning by experienced operators. The 
anthropometric measurements (weight and height, as well 
as upper arm, waist, and calf circumferences) were taken in 
accordance with standard international criteria.18 Body mass 
index (BMI: weight/height2 [kg/m2]) was also calculated.
The bioelectrical values of resistance (R, Ohm) and 
 reactance (Xc, Ohm) were obtained using the impedentiom-
eter analyzer BIA 101 (Akern, Florence, Italy), according 
to standard international criteria.19 The phase angle was 
calculated as arctan Xc/R (degrees) and the impedance 
(Z, Ohm) as (R2 + Xc2)0.5.
Classic BIVA was applied.14 Individual vectors, adjusted 
for height (R/H, Ohm/m; Xc/H, Ohm/m) in order to eliminate 
conductor length effect, can be projected on a Cartesian plane 
defined by R/H and Xc/H (R/Xc graph). Individual or sample 
characteristics can be compared with tolerance ellipses (50%, 
75%, and 95% of cases) representing the variability of the 
reference population (in this case, the whole sex-specific 
sample under study). The major axis refers to hydration 
status (dehydrated individuals tending towards the upper 
pole), and the minor axis refers to body cell mass (higher 
values on the left side).
Specific BIVA17 was also applied. In order to compensate 
for the effect of the whole conductor volume, bioelectrical val-
ues were multiplied by a correction factor (A/L, in meters) for 
which area (A) and length (L) were estimated as follows:
 A =  (0.45 ⋅ arm area + 0.10 ⋅ waist area  
+ 0.45 ⋅ calf area) (m2),
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where segment area = C2/4Л, and C (m) is the circumference 
of the arm, waist, and calf, respectively; L = 1.1 H (m). 
 Coefficients were attributed considering the differential con-
tribution of body segments to the whole body’s resistance19 
and the length proportions.20
These new bioelectrical variables, multiplied by a  factor 
of 100 to obtain the same order of magnitude as the classic 
values, represent a proxy of resistivity, or specific resistance 
(R sp, Ohm  cm), and reactivity, or specific reactance (Xc sp, 
Ohm  cm). Impedivity (Z sp, Ohm · cm) was calculated as 
follows: (R sp2 + Xc sp2)0.5. Phase angle values remained 
unchanged with respect to classic BIVA.
Specific resistance has a positive relation with the rela-
tive amount of fat mass, which explains the variation along 
the major axis of specific tolerance ellipses17 (Buffa et al, 
unpublished data, 2012), while specific reactance (Buffa et al, 
unpublished data, 2012), as well as the phase angle,21 
are mainly – negatively – related to extracellular/intracellular 
water (ECW/ICW) ratio.
DXA fan-beam technology (QDR 4500 W; Hologic Inc, 
Bedford, MA) was used to assess fat mass (FM
DXA
, kg), fat-
free mass (FFM
DXA
, kg) (ie, the sum of lean soft tissue mass 
and bone mineral content), the relative amount of fatness 
(FM
DXA
%), and the skeletal muscle mass index (SMI) (ie, 
the sum of lean mass of the four limbs (appendicular skel-
etal muscle mass [ASM]) corrected for the height squared: 
ASM/height2 (kg/m2)).22 DXA has good reproducibility in 
determining soft-tissue composition and a good agreement 
with other reference methods.23
Statistical analysis
The cut-offs for sarcopenia were defined by the SMI  values 
two standard deviations below the mean of a young sex-
specific Rosetta Study group (7.26 kg/m2 for men and 
5.45 kg/m2 for women), as suggested by Baumgartner et al.22 
The cut-offs for sarcopenic obesity corresponded to the sex-
specific median values of the FM
DXA
%. Both the median 
FM
DXA
% values of the Rosetta Study (27% for men and 38% 
for women)22 and of our sample were applied.
Differences in the anthropometric and body composition 
characteristics between groups with and without sarcopenia, 
and between sarcopenic obese and nonobese individuals, were 
assessed with Student’s t-test. Pearson’s product-moment corre-
lation coefficients between anthropometrical/bioelectrical values 
and body composition indicators were calculated. Given the sex-
related differences, all data analyses were stratified by sex.
The mean impedance vectors of groups with differing sar-
copenia status were compared with the Hotelling’s T 2 test and 
graphically compared with the 95% probability confidence 
ellipses. Mahalanobis distance D was also calculated.
Statistical analyses were performed using the free 
 software R and BIVA. All statistical tests were two-tailed, and 
statistical significance was assumed for a p-value , 0.05.
Results
On the basis of SMI values,22 sarcopenia was diagnosed in 
18 men (24.3% of the male sample) and in five women (3.9% 
of the female sample).
Sarcopenic individuals of both sexes showed lower weight 
(p , 0.01), circumference values (p , 0.01), BMI (p , 0.01), 
and quantities of FM
DXA
 and FFM
DXA
 (p , 0.01), with respect 
to nonsarcopenic individuals (Table 1).  Sarcopenic women 
also showed a lower percentage of FM
DXA
 (p , 0.05) and 
sarcopenic men a higher age (p , 0.01). Height was not 
significantly different between groups.
Classic BIVA detected significant differences between 
sarcopenic and nonsarcopenic groups (both sexes) due to 
the higher values of R/H, Z/H, and the lower phase angle of 
sarcopenic individuals (Table 1 and Figure 1), while Xc/H 
values were not different between groups.
Specific BIVA also recognized significant differences 
between sarcopenic and nonsarcopenic individuals (men: 
T2 = 15.7, p , 0.01; women: T2 = 10.7, p , 0.01), with the 
sarcopenic groups showing lower specific reactance and a 
lower phase angle (Table 1).
Phase angle was significantly correlated with ASM (men: 
r = 0.51, p , 0.01; women: r = 0.38, p , 0.05) and SMI (men: 
r = 0.52, p , 0.01; women: r = 0.31, p , 0.01).
According to the FM
DXA
% cut-offs of the Rosetta Study 
(27% for men and 38% for women),22 the number of sarcopenic 
obese individuals was very low: three men and no woman. 
Using the median FM
DXA
% values of the present sample 
(23.8% for men and 36.4% for women), eight sarcopenic men 
and one sarcopenic woman had a relative amount of fat higher 
than the sex-specific cut-offs. Because of the numerical paucity 
of the female sarcopenic individuals, the subsequent analyses 
were performed in men only. Sarcopenic obese men showed 
significantly higher BMI (p , 0.01), waist circumference 
(WC) (p , 0.01), and SMI (p , 0.01), but nonobese men 
had similar ages and weights. Specific BIVA, but not classic 
BIVA, detected significant differences (T2 = 13.4, p , 0.01) 
between groups (Table 2 and Figure 2), with specific resistance, 
reactance, and impedance being higher in the obese group; 
phase angle was not significantly different. The specific 
bioelectrical vectors of all sarcopenic-obese individuals were 
located on the right upper quadrant of the specific tolerance 
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Table 1 Descriptive and comparative statistics: sarcopenic versus nonsarcopenic individuals
Men Women
Sarcopenic 
(n = 18)
Nonsarcopenic 
(n = 54)
Sarcopenic 
(n = 5)
Nonsarcopenic 
(n = 123)
Mean SD Mean SD p Mean SD Mean SD p
Age 81.5 7.0 73.8 5.9 0.000 70.4 2.6 70.8 4.1 0.835
Anthropometric and body composition variables
height (cm) 169.2 7.9 170.3 6.0 0.552 155.4 7.5 156.2 5.6 0.746
Weight (kg) 65.8 7.3 79.2 9.9 0.000 51.8 10.7 66.0 7.9 0.000
Upper arm crf (cm) 26.6 3.9 30.8 3.2 0.000 27.7 2.8 30.2 2.5 0.030
Waist crf (cm) 88.2 9.4 98.0 9.4 0.000 78.6 5.2 95.0 13.1 0.006
Calf crf (cm) 33.7 2.5 36.9 2.8 0.000 32.1 3.4 35.8 2.7 0.004
BMI (kg/m2) 23.0 2.1 27.3 2.8 0.000 21.2 2.2 27.1 3.2 0.000
FM (kg) 14.8 4.5 19.5 5.6 0.002 16.7 6.1 24.2 5.1 0.002
FFM (kg) 49.5 4.6 58.0 5.8 0.000 34.6 4.3 40.6 3.9 0.001
FM% 21.9 5.3 23.9 4.7 0.135 30.7 5.4 36.0 4.4 0.011
SMI (kg/m2) 6.8 0.4 8.3 0.7 0.000 5.2 0.4 6.7 0.6 0.000
Bioelectrical variables
R/h (Ohm/m) 331.0 31.5 272.1 28.4 0.000 426.4 53.1 356.5 31.1 0.000
Xc/h (Ohm/m) 28.6 5.5 29.0 4.9 0.780 39.0 6.6 38.0 5.4 0.664
Z/h (Ohm/m) 332.2 31.5 273.7 28.3 0.000 428.2 53.4 358.6 31.2 0.000
R sp (Ohm • cm) 387.4 70.8 393.5 52.6 0.698 440.5 65.4 490.2 64.4 0.094
Xc sp (Ohm • cm) 33.7 8.8 42.4 10.3 0.002 40.2 7.3 52.5 10.6 0.012
Z sp (Ohm • cm) 388.9 71.1 395.9 53.0 0.662 442.4 65.7 493.0 64.9 0.090
Phase (degrees) 5.0 1.0 6.1 1.1 0.000 5.2 0.5 6.1 0.8 0.015
Abbreviations: BMI, body mass index; crf, circumference; FFM, fat-free mass; FM, fat mass; h, height; R, resistance; SD, standard deviation; SMI, skeletal muscle mass index; 
sp, specific; Xc, reactance; Z, impedance.
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Figure 1 Mean impedance vectors and confidence ellipses from groups with and 
without sarcopenia.
Abbreviations: D, Mahalanobis distance; h, height; R, resistance; Xc, reactance.
ellipses, with the vectors corresponding to the three men with 
FM
DXA
% values higher than 27% (median value of the Rosetta 
Study)22 outside the 95% ellipse (Figure 3).
Discussion
As shown by both classic BIVA14 and the newly proposed 
specific approach,17 sarcopenic individuals were characterized 
by peculiar bioelectrical characteristics. In particular, classic 
BIVA recognized a lower phase angle and a longer imped-
ance vector (due to the higher values of R/H) in sarcopenic 
individuals than in nonsarcopenic individuals. These results 
are consistent with the theoretical expectations of BIVA, as the 
sarcopenic mean impedance vector was located in the region 
of the RXc graph corresponding to lean individuals.14 In gen-
eral, a low phase angle is related to a low body cell mass14 and 
to a high ECW/ICW ratio.21 Castillo-Martínez et al24 found 
a low phase angle and a high R/H (but also, differently from 
us, low Xc/H values) in cachectic individuals. Norman et al16 
obtained a similar displacement of the impedance vector in 
patients with low hand grip strength. The authors interpreted 
such vector migration as indicative of low muscle function 
and suggested the use of BIVA in place of hand-grip strength 
tests when subjects are not cooperative.16
We cannot exclude the possibility that the peculiar bio-
electrical pattern found in sarcopenic individuals could be 
due to a loss of muscle function, as Norman et al16 suggest. 
However, it is certainly associated with the lower body cell 
mass, FFM in particular, of sarcopenic individuals.
Noticeably, the significant relation between phase angle 
and the reliable biomarkers of body cell mass (ASM and SMI) 
obtained in this research confirm the expectations of Piccoli 
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Table 2 Descriptive and comparative statistics: sarcopenic versus 
sarcopenic obese men
Sarcopenic 
(FM% # 23.8; 
n = 10)
Sarcopenic-obese 
(FM% . 23.8; 
n = 8)
Mean SD Mean SD p
Age 81.1 6.8 82.0 7.7 0.795
Anthropometric and body composition variables
height (cm) 171.6 8.9 166.3 5.8 0.165
Weight (kg) 63.8 8.3 68.3 5.3 0.200
Upper arm crf (cm) 25.3 2.8 28.3 4.7 0.110
Waist crf (cm) 83.2 7.6 94.4 7.9 0.007
Calf crf (cm) 33.2 2.6 34.3 2.4 0.394
BMI (kg/m2) 21.6 1.6 24.7 1.2 0.000
FM (kg) 11.6 3.1 18.9 2.1 0.000
FFM (kg) 50.2 5.4 48.5 3.4 0.438
SMI 6.5 0.3 7.0 0.2 0.002
Bioelectrical variables
R/h (Ohm/m) 327.0 37.3 335.9 23.7 0.567
Xc/h (Ohm/m) 26.8 4.8 30.8 5.7 0.122
Z/h (Ohm/m) 328.1 37.3 337.3 23.8 0.554
R sp (Ohm • cm) 348.7 49.0 435.9 65.2 0.005
Xc sp (Ohm • cm) 28.9 7.3 39.7 6.9 0.006
Z sp (Ohm • cm) 349.9 49.2 437.7 65.2 0.005
Phase (degrees) 4.7 1.0 5.3 0.9 0.269
Abbreviations: BMI, body mass index; crf, circumference; FFM, fat-free mass; FM, 
fat mass; h, height; R, resistance; SD, standard deviation; SMI, skeletal muscle mass 
index; sp, specific; Xc, reactance; Z, impedance.
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Figure 2 Mean impedance vectors and confidence ellipses from sarcopenic men with FM% higher or lower than the median value of the sex-specific whole sample. (A) 
Classic BIVA; (B) specific BIVA.
Abbreviations: D, Mahalanobis distance; FM, fat mass; H, height; R, resistance; sp, specific; Xc, reactance.
et al.14 These results are also in accordance with those of Kyle 
et al,25 who found a similar positive relation between reactance 
and ASM, but disagree with those of Pietrobelli et al,26 whose 
results showed that phase angle does not add significantly to 
BIA prediction models. Moreover, the lower phase angle of 
sarcopenic individuals can be related to a higher ECW/ICW 
ratio21 (Buffa et al, unpublished data, 2012), a parameter that 
can be associated in relation with BCM,27 which is, in turn, 
related to muscle mass.28 According to specific BIVA, and in 
particular on the basis of similar R sp values in sarcopenic 
and nonsarcopenic individuals, the mean differences in the 
relative quantity of fat mass were not evident (with a p-value 
slightly above the significance level in women). In effect, the 
FM
DXA
% mean differences were not significant in men, while 
in women they reached a significance level of p , 0.05 (higher 
FM
DXA
% values in nonsarcopenic women).
Interestingly, BMI was signif icantly higher in the 
“normal” groups (p , 0.01 in both sexes), showing that, as 
recently clearly stated by Thibault and Pichard,13 it is more 
an indicator of body mass than body composition.
Specific BIVA, but not classic BIVA, recognized bioelec-
trical differences between sarcopenic and sarcopenic obese 
men, as shown in Figure 2. The higher values of R sp in 
sarcopenic obese individuals indicated a greater proportion 
of fat in their bodies (Table 2). Moreover, the impedance 
vectors of all sarcopenic obese individuals were located in 
the upper right quadrant (Figure 3), a region of the specific 
tolerance ellipses that was recognized as corresponding to 
obesity17 (Buffa et al, unpublished data, 2012). The validation 
of appropriate cut-offs in a larger reference sample would 
confirm the suitability of this procedure for the diagnosis of 
sarcopenic obesity.
With respect to other standard clinical methods, such as 
DXA or MRI, BIVA has some methodological advantages. 
It can easily be performed by a single operator very quickly 
(less than 10 minutes per patient), is completely safe because 
no radiation exposure is needed, and has low maintenance 
and operational costs.
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With respect to other simple adiposity indexes, such as 
WC and BMI, BIVA appears more adequate in recogniz-
ing body composition variations. BIVA analyzes electrical 
properties of tissues and is sensitive to changes of body cell 
mass and hydration;14,15 specific BIVA17 has been shown to 
accurately evaluate the relative amounts of fat and FFM, 
so it is probably sensitive to skeletal muscle fat infiltration 
and inflammatory states. According to Siervo et al,29 BMI 
and WC showed the worst performance when classifying 
sarcopenic obesity in a large sample of women. Moreover, 
the visceral fat distribution detected by WC is a dimorphic 
character more pronounced in men than in women; in fact, 
even though in the present research WC showed significant 
differences between sarcopenic and sarcopenic obese men 
(Table 2), in women the correlation of WC with FM% (r: 0.42, 
p , 0.01) was lower than the correlation between R sp and 
FM% (r: 0.62, p . 0.01).
Conclusion
BIVA was confirmed to be a useful technique for detecting 
muscle-mass variations in sarcopenic individuals, with spe-
cific BIVA able to discriminate sarcopenic from sarcopenic 
obese individuals. These low-cost, simple procedures are 
promising tools that allow a bicompartmental evaluation of 
body composition, and they could be used for the screening 
of presarcopenia (as defined by EWGSOP, 2010), sarcopenia, 
and sarcopenic obesity in routine practice.
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